VIRGINIA BEACH, Va. (March 12, 2021) — LifeNet Health LifeSciences will showcase its portfolio of innovative human cell- and tissue-based research solutions — including the new, all-human Tri-Culture model, thyrocytes for use in 3D models and genotyped human hepatocytes — at the Society of Toxicology (SOT) virtual annual meeting and ToxExpo at booth #1322. LifeSciences provides researchers human-relevant research solutions to optimize outcomes and speed the drug discovery process.

Virginia Beach, Va., (Feb. 23, 2021) —Training Magazine, a leading business publication for workforce development programs, has recognized LifeNet Health for the second consecutive year as one of the world’s leading organizations for employee training. Last year, LifeNet Health’s ranking was placed at 70 and this year moved up to 34 out of 100 organizations.

VIRGINIA BEACH, Va. (Feb. 3, 2021) — LifeNet Health LifeSciences has successfully isolated three types of primary human lung epithelial cells from a single donor. One of the three types, alveolar epithelial type II cells, are of particular interest to scientists due to their applicability for respiratory disease research. LifeNet Health’s scientists have also isolated the bronchial and small airway epithelial cells, which are critical for the first lines of defense in protecting the lungs.

VIRGINIA BEACH, Va. (Jan. 13, 2021) — LifeNet Health announced today the launch of their newly expanded LifeSciences division which is offering human cell- and tissue-based research solutions through a new website, LNHLifeSciences.org.

VIRGINIA BEACH, Va. (Jan. 8, 2021) — LifeNet Health, Virginia’s federally designated Organ Procurement Organization (OPO), coordinated a record 616 organ transplants in 2020, exceeding the previous year’s record by 31 organs. It is the third consecutive record year for transplants in LifeNet Health’s service area. In all, 237 organ donors saved the lives of 555 patients — some of whom received multiple organs —through the selfless gift of donation.

Recent peer-reviewed publications continue to demonstrate the clinical advantage of ViviGen’s
lineage-committed, viable bone cells in high-risk foot and ankle procedures

Virginia Beach, Va. (Dec. 9, 2020) — LifeNet Health, the global leader in sports medicine biologic solutions, today launched a new web portal that makes ordering custom-matched, highly specialized “fresh” osteochondral allografts (OCAs) easy. The platform will be featured Dec. 10-12 in LifeNet Health’s exhibit at the 2020 Orthopedic Summit and Emerging Technologies (OSET) virtual conference.

Virginia Beach, Va. (Dec. 8, 2020) — Health services company Cigna has recognized LifeNet Health with its 2020 Culture of Wellbeing award for its focus on employee wellness — including programs focused on physical, mental and financial wellbeing. 

LifeNet Health is one of just three companies across the country to receive the award this year. Presented annually, the Culture of Wellbeing awards are given to organizations that demonstrate a commitment to improving and sustaining the overall health and wellbeing of their workforce. 

Virginia Beach, Va. (Nov. 23, 2020) — ViviGen^® Cellular Bone Matrix is associated with significantly lower hospital costs compared to recombinant human bone morphogenetic protein-2 (rhBMP-2), according to an analysis of more than 16,000 U.S. lumbar fusions procedures.

Virginia Beach, Va. (Nov. 4, 2020) — LifeNet Health, the global leader in regenerative medicine biologics, is creating new possibilities in patient care with Matrion^TM, a breakthrough decellularized placental membrane for wound healing. Currently in limited release with select surgeons in the U.S., Matrion will be available nationally in early 2021.